Application and follow-up of the peripheral neuropathic pain treatment with capsaicin 179 mg conducted by nurses

Section: Originals

How to quote

Reta Murua A, Sarubbo MF, March Sánchez Y, Ruiz Villamayor R, Manso Fernández M, Coves Uroz A, Ribas Luzón JA, Peláez Romero R. Aplicación y seguimiento del tratamiento del dolor neuropático periférico con capsaicina 179 mg realizado por enfermeras. Metas Enferm jul/ago 2022; 25(6):57-63. Doi: https://doi.org/10.35667/MetasEnf.2022.25.1003081959

Authors

Ainhoa Reta Murua1,4, María Fiorella Sarubbo2,3, Yolanda March Sánchez1,4, Raquel Ruiz Villamayor1, Mónica Manso Fernández1, Angela Coves Uroz1, José Antonio Ribas Luzón1, Raquel Peláez Romero4,5

Position

1Diploma Universitario en Enfermería, Unidad del dolor, Hospital Universitario Son Llàtzer. Palma, Mallorca (España) 2Doctora en Neurociencias, Unidad de Investigación, Hospital Universitario Son Llàtzer, Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa). Palma, Mallorca (España)3Universidad de las Islas Baleares (UIB), Facultad de Ciencias y Facultad de Medicina. Palma, Mallorca (España)4Grupo de investigación IdISBa en Medicina Perioperatoria, prevención y estrategias de mejora del dolor agudo y crónico. Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa). Hospital Universitario Son Espases (HUSE). Palma, Mallorca (España) 5Doctora y facultativo especialista en anestesiología. Unidad del dolor. Hospital Universitario Son Llàtzer. Palma, Mallorca (España)

Contact address

Ainhoa Reta Murua. Unidad del dolor. Hospital Universitario Son Llàtzer. Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa). Crta. Ma

Contact email: ainhoareta@gmail.com

Abstract

Objective: to evaluate the efficacy of the treatment with capsaicin 179mg patches applied and on follow-up by nurses in persons with peripheral neuropathic pain.
Method: a longitudinal retrospective series of cases conducted at the Pain Unit of the Hospital Universitario Son Llàtzer between 2018 and 2020. The study population consisted of 196 persons with that treatment. Basal measurement was conducted at one month, at three and six months. The following were measured: gender, age, time of evolution, applications conducted, improvement in intensity (NPRS scale: 0 to 10 points) and extent of pain, health-related quality of life (EQ-5D-3L: 0=the worst to 1=the best), patient global impression of improvement (PGI-I: improvement, worsening or no improvement), use of adjuvant drugs and side effects. Descriptive statistics was applied.
 Results: 133 patients were included with complete records
(= 57 years; = 30.2 months of evolution; = 1.6 applications per person). There was a reduction in the pain area [Reduced (Month 1: 67%; Month 3: 41%; Month 6: 20%)] and pain intensity moved from = 7.35 to 6.32 at month six. Quality of life was superior to the mean baseline (0.37 of 1) in all measurements. There was improvement in PGI [Improvement (Month 1: 64.6%: Month 3: 58.9%; Month 6: 53.6 %)]. There was a reduction in the use of adjuvant medication [Reduced (Month 1: 28%; Month 3: 30%; Month 6: 67%)]. The adverse effects were pain (78.9%), erythema (67.7%) and itching (63.9%).
Conclusion: the treatment applied by nurses was effective and safe. There must be follow-up at long term in order to detect any needs and changes.

Keywords:

nurses; nurse’s role; pain clinics; capsaicin; peripheral neuropathic pain; pain; neuralgia; analgesia; follow-up studies

Versión en Español

Título:

Aplicación y seguimiento del tratamiento del dolor neuropático periférico con capsaicina 179 mg realizado por enfermeras